Eliminate Malaria

We are committed to making a major contribution in efforts to eliminate malaria as a public health threat, particularly in our region.

One of the leading causes of mortality and morbidity globally, malaria was responsible for around 438,000 deaths and 214 million clinical cases in 2015. An estimated 3.2 billion people are at risk of the disease, with young children and pregnant women most affected.

A two-way pipeline will be created where our research discoveries can be tested in the field, and field programs inform discovery research through our long-standing connections with vulnerable target populations, especially in Papua New Guinea and Myanmar.

Through this program, Burnet will contribute to:

  • reaching the WHO elimination targets of a 90 percent reduction in malaria incidence and mortality through an active program of basic, discovery and translational research and in-field education, prevention and treatment programs.

  • supporting country programs in our region that assist WHO in reaching targets of elimination in at least 35 countries by 2030.


Contact Details

Professor James Beeson

Deputy Director (People); Head of Malaria Research: Immunity, Vaccines and New Therapies Laboratory; Adjunct Professor Monash University






Latest News

  • 04 December, 2018

    Img 2862 135x132

    A Fenner Award first

    For the first time, Burnet’s prestigious Frank Fenner Award has joint winners - Associate Professor Freya Fowkes and Professor Mark Stoové.

  • 09 November, 2018

    Img 7980 135x132

    Focus on malaria immunity

    New Burnet research has revealed important insights into malaria immunity that could support the development of a world-first effective malaria vaccine.

Upcoming Events

  • 25 April, 2019

    World malaria day logo 135x132

    World Malaria Day

    Malaria remains endemic in around 100 countries with more than three billion people at risk.